Advertisement
Canada markets open in 2 hours 59 minutes
  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CAD/USD

    0.7295
    -0.0006 (-0.08%)
     
  • CRUDE OIL

    81.79
    -0.11 (-0.13%)
     
  • Bitcoin CAD

    90,718.20
    +167.20 (+0.18%)
     
  • CMC Crypto 200

    1,421.84
    +7.08 (+0.50%)
     
  • GOLD FUTURES

    2,313.60
    -32.80 (-1.40%)
     
  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • NASDAQ futures

    17,400.50
    +50.50 (+0.29%)
     
  • VOLATILITY

    16.68
    -0.26 (-1.53%)
     
  • FTSE

    8,061.90
    +38.03 (+0.47%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6842
    -0.0008 (-0.12%)
     

Top Ranked Momentum Stocks to Buy for December 2nd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 2nd:

Jounce Therapeutics, Inc. (JNCE): This clinical-stage immunotherapy company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.1% over the last 60 days.

Jounce Therapeutics, Inc. Price and Consensus

Jounce Therapeutics, Inc. Price and Consensus
Jounce Therapeutics, Inc. Price and Consensus

Jounce Therapeutics, Inc. price-consensus-chart | Jounce Therapeutics, Inc. Quote

Jounce Therapeutics’ shares gained 39.4% over the last one month above the S&P 500’s increase 2%. The company possesses a Momentum Score of A.

Jounce Therapeutics, Inc. Price

Jounce Therapeutics, Inc. Price
Jounce Therapeutics, Inc. Price

Jounce Therapeutics, Inc. price | Jounce Therapeutics, Inc. Quote

ADVERTISEMENT

Guardant Health, Inc. (GH): This precision oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.7% over the last 60 days.

Guardant Health, Inc. Price and Consensus

Guardant Health, Inc. Price and Consensus
Guardant Health, Inc. Price and Consensus

Guardant Health, Inc. price-consensus-chart | Guardant Health, Inc. Quote

Guardant Health’s shares gained 8.7% over the last one month. The company possesses a Momentum Score of A.

Guardant Health, Inc. Price

Guardant Health, Inc. Price
Guardant Health, Inc. Price

Guardant Health, Inc. price | Guardant Health, Inc. Quote

Target Corporation (TGT): This general merchandise retailer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

Target Corporation Price and Consensus

Target Corporation Price and Consensus
Target Corporation Price and Consensus

Target Corporation price-consensus-chart | Target Corporation Quote

Target’s shares gained 14.9% over the last one month. The company possesses a Momentum Score of A.

Target Corporation Price

Target Corporation Price
Target Corporation Price

Target Corporation price | Target Corporation Quote

Teekay Tankers Ltd. (TNK): This maritime transportation providing company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Teekay Tankers Ltd. Price and Consensus

Teekay Tankers Ltd. Price and Consensus
Teekay Tankers Ltd. Price and Consensus

Teekay Tankers Ltd. price-consensus-chart | Teekay Tankers Ltd. Quote

Teekay Tankers’ shares gained 9.4% over the last one month. The company possesses a Momentum Score of A.

Teekay Tankers Ltd. Price

Teekay Tankers Ltd. Price
Teekay Tankers Ltd. Price

Teekay Tankers Ltd. price | Teekay Tankers Ltd. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

See 5 Stocks Set to Double>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Teekay Tankers Ltd. (TNK) : Free Stock Analysis Report
 
Target Corporation (TGT) : Free Stock Analysis Report
 
Jounce Therapeutics, Inc. (JNCE) : Free Stock Analysis Report
 
Guardant Health, Inc. (GH) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research